All IndicationsInfectious Disease
🦠
SARS-CoV-2 Infection, COVID-19
1
Companies
1
Drug Programs
1
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| BNTX BioNTech SE | Biological/Vaccine: BNT162b2 10mcg | Phase 3 | — | — | — |
Development Stage Distribution
Phase 3
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.
